Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism
Venkatesh Krishnan(Eli Lilly (United States)), Henry U. Bryant(Eli Lilly (United States)), Mary D. Adrian(Eli Lilly (United States)), Charles Benson(Eli Lilly (United States)), André M. Pilon(National Center for Advancing Translational Sciences), Wei Zheng(Liaoning Cancer Hospital & Institute), Lifei Liu(Eli Lilly (United States)), Gregory J. Tawa(National Institutes of Health), Christy Javella‐Cauley(Eli Lilly (United States)), Yanfei Li(Eli Lilly (United States)), Wei‐Ming Li(Kaohsiung Medical University), Masahiko Sato(Tokyo University of Science), Natasha Thorne(National Institutes of Health), Wayne D. Kohn(University of Alberta), Heather A. Bullock(Eli Lilly (United States)), N. Nora Yang(National Center for Advancing Translational Sciences), Shaoyou Chu(Eli Lilly (United States)), Catherine Z. Chen(National Institutes of Health)
Cited by 16
Related Papers
Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.
|Journal of Clinical Investigation|1991|1k
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2015|348
A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
|Journal of Bone and Mineral Research|2014|291
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
|Emerging Microbes & Infections|2014|242